Vanda Pharmaceuticals (VNDA) Tax Provisions (2010 - 2026)

Vanda Pharmaceuticals has reported Tax Provisions for 12 years, with the latest figure at $100000.0 in Q1 2026.

• Quarterly Tax Provisions rose 101.27% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.8 million (up 888.07% YoY) and the FY2025 annual result came in at $81.8 million, up 2134.99% from the prior year.
• Tax Provisions slipped to $100000.0 in Q1 2026 per VNDA's latest filing, from $103.2 million in the prior quarter.
• Over five years, Tax Provisions peaked at $103.2 million in Q4 2025 and troughed at -$7.9 million in Q1 2025.
• A 5-year average of $5.1 million and a median of -$257000.0 in 2023 frame the typical range for Tax Provisions.
• The widest YoY moves for Tax Provisions: up 6465.52% in 2025, down 1420.08% in 2025.
• Over 5 years, Tax Provisions stood at $2.8 million in 2022, then sank by 73.47% to $730000.0 in 2023, then slumped by 322.05% to -$1.6 million in 2024, then soared by 6465.52% to $103.2 million in 2025, then sank by 99.9% to $100000.0 in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $100000.0, $103.2 million, and -$5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.